Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT04990609

EUS-RFA PANCARDINAL-1 Trial

Led by The University of Texas Health Science Center, Houston · Updated on 2025-05-21

60

Participants Needed

1

Research Sites

354 weeks

Total Duration

On this page

Sponsors

T

The University of Texas Health Science Center, Houston

Lead Sponsor

N

National Cancer Institute (NCI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The objectives of this study are to determine the feasibility, tolerability, and treatment effect of endoscopic ultrasound (EUS) radiofrequency ablation (RFA) plus standard-of-care neoadjuvant chemotherapy (NAC) in the treatment of pancreatic ductal adenocarcinoma (PDAC). Endoscopic ultrasound (EUS) radiofrequency ablation (RFA) and neoadjuvant chemotherapy (NAC) will be performed before tumor resection surgery, with the goal of shrinking a tumor or stopping the spread of cancer so that surgery might be less invasive and more effective.

CONDITIONS

Official Title

EUS-RFA PANCARDINAL-1 Trial

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed and histologically-confirmed pancreatic ductal adenocarcinoma by biopsy
  • Have a permanent street address
  • Consent to study participation
  • Have an axial CT scan consistent with pancreatic ductal adenocarcinoma
  • No prior chemotherapy or less than 2 months of pre-operative chemotherapy for pancreatic ductal adenocarcinoma
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
Not Eligible

You will not qualify if you...

  • Younger than 18 years of age
  • No permanent street address or telephone number
  • Pregnant patients
  • Inmates or prisoners
  • Unable to provide informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Memorial Hermann Hospital

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

S

Sofia C Colon, BS

CONTACT

N

Nirav Thosani, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

EUS-RFA PANCARDINAL-1 Trial | DecenTrialz